Ophthalmology Times: New Collaboration to Enhance Eye Care Products

Wednesday, 11 September 2024, 07:45

Ophthalmology Times highlights the collaboration between Sonoma Pharmaceuticals and EMC Pharma to co-market an expanded eye care product line. This initiative focuses on patented Microcyn technology-based products, enhancing options for eye care. The new product line will be unveiled at the American Academy of Ophthalmology's annual meeting in October 2024.
Ophthalmologytimes
Ophthalmology Times: New Collaboration to Enhance Eye Care Products

Collaboration Overview

Ophthalmology Times reports that Sonoma Pharmaceuticals Inc. and EMC Pharma have entered into a co-marketing agreement to roll out an expanded prescription and OTC eye care product line. The product line focuses on patented Microcyn technology, emphasizing stabilized hypochlorous acid (HOCl) solutions for various eye care applications.

Product Innovations

Among the innovative products, the Ocucyn Eyelid and Eyelash Cleanser will feature a refreshed design and improved packaging. The complete product lineup will be presented at the American Academy of Ophthalmology's annual meeting scheduled for October 18 to 21, 2024, in Chicago.

Strengthening Market Reach

Since 2021, EMC Pharma has had exclusive rights to market and distribute Sonoma's HOCl-based eye care and prescription dermatology products in the United States. This new agreement extends EMC’s rights to include the over-the-counter Ocucyn and grants Sonoma additional rights for Acuicyn Eyelid and Eyelash Cleanser—which ophthalmologists can prescribe and utilize in their clinics.

  1. Ocucyn: Daily eye hygiene solution for itch and irritation.
  2. Acuicyn: Prescription-strength formula for managing chronic eye conditions.

Customer-Centric Design

Both Ocucyn and Acuicyn utilize hypochlorous acid solutions to gently cleanse the eye area, effectively removing dirt, oil, debris, and microorganisms. The consumer-friendly packaging of Ocucyn will feature a user-friendly single-piece dispensing mechanism, promoting ease of use.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe